Chapter 15

Constitutional Issues in the Use of Pharmacogenomic Variations Associated with Race

John A. Robertson J.D.

John A. Robertson J.D.

School of Law, University of Texas at Austin, Austin, TX, USA

Search for more papers by this author
First published: 10 January 2003
Citations: 3

Summary

Medical evidence now indicates that some racial and ethnic groups react differently to some drugs and therapies than other groups. Developing effective therapies for all racial and ethnic groups may mean taking their race or ethnicity into account in screening for disease or in prescribing therapy. When a close medical connection can be shown, the use of racial and ethnic categories in research and clinical care may be constitutional as a way of ensuring good health care for those groups.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.